Cite
HARVARD Citation
Boland, K. et al. (2020). Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing. Inflammatory bowel diseases. 26 (5), pp. 766-773. [Online].